Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152551 | 12615255 | 1 | I | 20160725 | 20160802 | 20160802 | EXP | AU-MYLANLABS-2016M1031450 | MYLAN | BARTON J, WONG A, GRAUDINS A. ANTI-XA ACTIVITY IN APIXABAN OVERDOSE: A CASE REPORT. CLIN-TOXICOL-(PHILA) 2016;:1-6. | 0.00 | Y | 0.00000 | 20160802 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152551 | 12615255 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 7 X 40MG | 91226 | ||||||||||
| 126152551 | 12615255 | 2 | SS | BISOPROLOL | BISOPROLOL | 1 | Unknown | 42 X 2.5MG | 0 | ||||||||||
| 126152551 | 12615255 | 3 | SS | MAGNESIUM | MAGNESIUM | 1 | Unknown | 10 X 3.74MG | 0 | ||||||||||
| 126152551 | 12615255 | 4 | SS | RAMIPRIL MYLAN | RAMIPRIL | 1 | Unknown | 28 X 1.25MG | 0 | ||||||||||
| 126152551 | 12615255 | 5 | SS | COLCHICINE. | COLCHICINE | 1 | Unknown | 12 X 0.5MG | 0 | ||||||||||
| 126152551 | 12615255 | 6 | SS | CODEINE PHOSPHATE W/PARACETAMOL/PHENYLEPHRINE | ACETAMINOPHENCODEINEPHENYLEPHRINE | 1 | Unknown | 500MG OF PARACETAMOL/ 9.5MG OF CODEINE/5MG OF PHENYLEPHRINE; TOTAL 4 UNITS | 0 | ||||||||||
| 126152551 | 12615255 | 7 | SS | APIXABAN | APIXABAN | 1 | Unknown | 0 | |||||||||||
| 126152551 | 12615255 | 8 | SS | APIXABAN | APIXABAN | 1 | Unknown | 40 X 5 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126152551 | 12615255 | 1 | Product used for unknown indication |
| 126152551 | 12615255 | 2 | Product used for unknown indication |
| 126152551 | 12615255 | 3 | Product used for unknown indication |
| 126152551 | 12615255 | 4 | Product used for unknown indication |
| 126152551 | 12615255 | 5 | Product used for unknown indication |
| 126152551 | 12615255 | 6 | Product used for unknown indication |
| 126152551 | 12615255 | 7 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126152551 | 12615255 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126152551 | 12615255 | Haemorrhage | |
| 126152551 | 12615255 | Hypotension | |
| 126152551 | 12615255 | Intentional overdose | |
| 126152551 | 12615255 | International normalised ratio increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |